These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38662144)

  • 21. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
    Bezerra Salomão K; Cruzeiro GAV; Bonfim-Silva R; Geron L; Ramalho F; Pinto Saggioro F; Serafini LN; Antunes Moreno D; de Paula Queiroz RG; Dos Santos Aguiar S; Cardinalli I; Yunes JA; Brandalise SR; Brassesco MS; Scrideli CA; Gonzaga Tone L
    J Neurooncol; 2018 Aug; 139(1):33-42. PubMed ID: 29582271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk stratification in medulloblastoma: screening for molecular markers].
    Ebinger M; Senf L; Scheurlen W
    Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
    Andrade AF; Borges KS; Suazo VK; Geron L; Corrêa CA; Castro-Gamero AM; de Vasconcelos EJ; de Oliveira RS; Neder L; Yunes JA; Dos Santos Aguiar S; Scrideli CA; Tone LG
    Invest New Drugs; 2017 Feb; 35(1):26-36. PubMed ID: 27785591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
    Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [miR-449a is a potential epigenetic biomarker for WNT subtype of medulloblastoma].
    Li YX; Shao LW; Jiang T; Liu Y; Chang Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):684-689. PubMed ID: 29050069
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of FAT1 gene expression on the prognosis of medulloblastoma in children: A protocol for systematic review and meta-analysis.
    Yu J; Gao H; Su Z; Yue F; Tian X
    Medicine (Baltimore); 2020 Nov; 99(46):e23020. PubMed ID: 33181666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.
    Raso A; Mascelli S; Biassoni R; Nozza P; Kool M; Pistorio A; Ugolotti E; Milanaccio C; Pignatelli S; Ferraro M; Pavanello M; Ravegnani M; Cama A; Garrè ML; Capra V
    Neuro Oncol; 2011 May; 13(5):500-8. PubMed ID: 21486962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients.
    Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Tarasińska M; Perek-Polnik M; Krętowski A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Matyja E
    Am J Surg Pathol; 2017 Jun; 41(6):781-787. PubMed ID: 28338501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
    Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
    Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
    Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
    Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
    Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
    Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    Kumar R; Smith KS; Deng M; Terhune C; Robinson GW; Orr BA; Liu APY; Lin T; Billups CA; Chintagumpala M; Bowers DC; Hassall TE; Hansford JR; Khuong-Quang DA; Crawford JR; Bendel AE; Gururangan S; Schroeder K; Bouffet E; Bartels U; Fisher MJ; Cohn R; Partap S; Kellie SJ; McCowage G; Paulino AC; Rutkowski S; Fleischhack G; Dhall G; Klesse LJ; Leary S; Nazarian J; Kool M; Wesseling P; Ryzhova M; Zheludkova O; Golanov AV; McLendon RE; Packer RJ; Dunham C; Hukin J; Fouladi M; Faria CC; Pimentel J; Walter AW; Jabado N; Cho YJ; Perreault S; Croul SE; Zapotocky M; Hawkins C; Tabori U; Taylor MD; Pfister SM; Klimo P; Boop FA; Ellison DW; Merchant TE; Onar-Thomas A; Korshunov A; Jones DTW; Gajjar A; Ramaswamy V; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):807-821. PubMed ID: 33502920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
    Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
    Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automatic image segmentation and online survival prediction model of medulloblastoma based on machine learning.
    Zhou L; Ji Q; Peng H; Chen F; Zheng Y; Jiao Z; Gong J; Li W
    Eur Radiol; 2024 Jun; 34(6):3644-3655. PubMed ID: 37994966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.